Anesthetic Management of Glucose-6-Phosphate Dehydrogenase Deficiency in Cardiac Surgery: A Narrative Review
Journal of Cardiothoracic and Vascular Anesthesia · 2026-10
DOI: 10.1053/j.jvca.2026.10.021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cardiothoracic and Vascular Anesthesia, 2026-10. Verfasst von Seth White und 4 weiteren Autor:innen. Beteiligte Einrichtung: Loma Linda University Medical Center, Department of Anesthesiology, Loma Linda, CA. Die Arbeit nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Global prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency approaches 450 million individuals. G6PD deficiency impairs management of oxidative stress and has been associated with premature development of coronary atherosclerosis. Anesthesia, cardiac surgery, and cardiopulmonary bypass (CPB) may exacerbate oxidative stress. This review article summarizes literature pertaining to perioperative management of individuals with G6PD deficiency undergoing cardiac surgery. Perioperative care for individuals with G6PD deficiency centers on avoidance of oxidative stress and triggering medications. Although many anesthetic medications have been safely used in G6PD-deficient populations, emerging evidence suggests propofol, dexmedetomidine, and remifentanil have pleiotropic antioxidant properties. Cardiac surgery and CPB potentially instigate erythrocyte trauma and promote oxidative stress. Centrifugal pumps avoid mechanical deformation of red cells and generate a significantly lower inflammatory response than roller pumps. While selection of large vascular cannulae promotes laminar flow and imparts less shear stress on erythrocytes, minimized CPB circuitry reduces the nonbiologic contact interface with erythrocytes and is associated with less inflammation than conventional CPB circuitry. Moreover, maintenance of normothermia during CPB may help prevent hemolysis in individuals with G6PD deficiency by preserving red cell deformability. Importantly, transient acidemia during CPB may potentially trigger hemolysis in G6PD-deficient individuals, and the balance between perfusion supply and demand warrants consideration. Strategies to mitigate intraoperative hemolysis in G6PD-deficient individuals are needed to support safe perioperative care. Intraoperative care demands vigilance for signs of hemolysis to support prompt diagnosis and management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Loma Linda University Medical Center, Department of Anesthesiology, Loma Linda, CA.
- Loma Linda University School of Medicine, Department of Pathology and Human Anatomy, Loma Linda, CA.
- Loma Linda University Medical Center, Department of Anesthesiology, Loma Linda, CA. Electronic address: mmccabe@llu.edu.
Zitieren
APA
White, S., Mekala, P., Reynoso, E. E., Herrmann, P., & McCabe, M. D. (2026). Anesthetic Management of Glucose-6-Phosphate Dehydrogenase Deficiency in Cardiac Surgery: A Narrative Review. Journal of Cardiothoracic and Vascular Anesthesia. https://doi.org/10.1053/j.jvca.2026.10.021
Vancouver
White S, Mekala P, Reynoso EE, Herrmann P, McCabe MD. Anesthetic Management of Glucose-6-Phosphate Dehydrogenase Deficiency in Cardiac Surgery: A Narrative Review. Journal of Cardiothoracic and Vascular Anesthesia. 2026. doi:10.1053/j.jvca.2026.10.021
BibTeX
@article{White2026,
author = {White, Seth and Mekala, Preethi and Reynoso, Edgardo E and Herrmann, Paul and McCabe, Melissa D},
title = {Anesthetic Management of Glucose-6-Phosphate Dehydrogenase Deficiency in Cardiac Surgery: A Narrative Review},
journal = {Journal of Cardiothoracic and Vascular Anesthesia},
year = {2026},
doi = {10.1053/j.jvca.2026.10.021}
}
EUVIMED